AAAAAA
Results:
1-14
|
Results: 14
Authors:
Brennan, PA
Palacios-Callender, M
Zaki, GA
Spedding, AV
Langdon, JD
Citation: Pa. Brennan et al., Does type II nitric oxide synthase expression correlate with cellular proliferation in oral squamous cell carcinoma and dysplasia?, HEAD NECK, 23(3), 2001, pp. 217-222
Authors:
Brennan, PA
Palacios-Callender, M
Zaki, GA
Spedding, AV
Langdon, JD
Citation: Pa. Brennan et al., Type II nitric oxide synthase (NOS2) expression correlates with lymph nodestatus in oral squamous cell carcinoma, J ORAL PATH, 30(3), 2001, pp. 129-134
Authors:
Pateromichelakis, S
Lee, G
Langdon, JD
Partridge, M
Citation: S. Pateromichelakis et al., The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon, ORAL ONCOL, 36(2), 2000, pp. 180-188
Authors:
Partridge, M
Li, SR
Pateromichelakis, S
Francis, R
Phillips, E
Huang, XH
Tesfa-Selase, F
Langdon, JD
Citation: M. Partridge et al., Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment, CLIN CANC R, 6(7), 2000, pp. 2718-2725
Authors:
Brennan, PA
Umar, T
Palacios-Callender, M
Spedding, AV
Mellor, TK
Buckley, J
Langdon, JD
Citation: Pa. Brennan et al., A study to assess inducible nitric oxide synthase expression in oral lichen planus, J ORAL PATH, 29(6), 2000, pp. 249-254
Authors:
Brennan, PA
Umar, T
Zaki, GA
Langdon, JD
Spedding, A
Buckley, J
Downie, IP
Citation: Pa. Brennan et al., Are myoepithelial cells responsible for the widespread expression of inducible nitric oxide synthase in pleomorphic adenoma? An immunohistochemical study, J ORAL PATH, 29(6), 2000, pp. 279-283
Authors:
Avery, CME
Moody, AB
McKinna, FE
Taylor, J
Henk, JM
Langdon, JD
Citation: Cme. Avery et al., Combined treatment of adenoid cystic carcinoma of the salivary glands, INT J OR M, 29(4), 2000, pp. 277-279
Authors:
Moody, AB
Avery, CME
Walsh, S
Sneddon, K
Langdon, JD
Citation: Ab. Moody et al., Surgical management of chronic parotid disease, BR J ORAL M, 38(6), 2000, pp. 620-622
Correlation between type II nitric oxide synthase and p53 expression in oral squamous cell carcinoma
Authors:
Brennan, PA
Palacios-Callender, M
Umar, T
Hughes, D
Spedding, AV
Zaki, GA
Langdon, JD
Citation: Pa. Brennan et al., Correlation between type II nitric oxide synthase and p53 expression in oral squamous cell carcinoma, BR J ORAL M, 38(6), 2000, pp. 627-632
Authors:
Brennan, PA
Umar, T
Bunckley, J
Zaki, GA
Langdon, JD
Spedding, A
Peters, W
Citation: Pa. Brennan et al., Expression of nitric oxide synthase in pleomorphic adenomas of the parotid, BR J ORAL M, 38(4), 2000, pp. 338-342
Authors:
Partridge, M
Pateromichelakis, S
Phillips, E
Emilion, GG
A'Hern, RP
Langdon, JD
Citation: M. Partridge et al., A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization, CANCER RES, 60(14), 2000, pp. 3893-3898
Authors:
Partridge, M
Kiguwa, S
Emilion, G
Pateromichelakis, S
A'Hern, R
Langdon, JD
Citation: M. Partridge et al., New insights into p53 protein stabilisation in oral squamous cell carcinoma, ORAL ONCOL, 35(1), 1999, pp. 45-55
Authors:
Moody, AB
Avery, CME
Taylor, J
Langdon, JD
Citation: Ab. Moody et al., A comparison of one hundred and fifty consecutive parotidectomies for tumours and inflammatory disease, INT J OR M, 28(3), 1999, pp. 211-215
Authors:
Brennan, PA
Downie, IP
Langdon, JD
Zaki, GA
Citation: Pa. Brennan et al., Emerging role of nitric oxide in cancer, BR J ORAL M, 37(5), 1999, pp. 370-373
Risultati:
1-14
|